Prespecified subgroup (secondary) analysis of AGENT IDE (597 patients with in-stent restenosis): paclitaxel-coated balloons cut 1-year target lesion failure vs uncoated balloons in small vessels (17.7% vs 27.4%; HR 0.61) and large vessels (18.4% vs 30.5%; HR 0.57).
Secondary analysisn = 597 patients
Wen et al. Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial